Pulmonx Corp

LUNG Nasdaq CIK: 0001127537

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation DE
Business Address 700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Mailing Address 700 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
Phone 650-364-0400
Fiscal Year End 1231
EIN 000000000

Financial Overview

FY2025

$162.85M
Total Assets
$77.04M
Total Liabilities
$70.91M
Cash & Equivalents

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment March 27, 2026 View on SEC
10-K Annual financial report March 10, 2026 View on SEC
SCHEDULE 13G Passive beneficial ownership (>5%) March 9, 2026 View on SEC
8-K Current report of material events March 5, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
8-K Current report of material events March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
4 Insider stock transaction report March 4, 2026 View on SEC
3 Initial insider ownership report December 10, 2025 View on SEC

Annual Reports

10-K March 10, 2026
  • Pulmonx Corp achieved a strong 25% revenue growth, reaching $150.5 million in 2025, driven by increased sales of its Zephyr Valve system.
  • The company significantly improved its net loss, reducing it from $75.1 million in 2024 to $62.8 million in 2025, indicating a positive profitability trend.
View Analysis

Insider Trading

SELL 5 insiders 16 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.